ASTM-E2721:2010 Edition
$40.63
E2721-10 Standard Test Method for Evaluation of Effectiveness of Decontamination Procedures for Surfaces When Challenged with Droplets Containing Human Pathogenic Viruses
Published By | Publication Date | Number of Pages |
ASTM | 2010 | 10 |
1.1 This test method is designed to evaluate decontamination methods (physical, chemical, self-decontaminating materials) when used on surfaces contaminated with virus-containing droplets.
1.2 This test method defines the conditions for simulating respiratory droplets produced by humans and depositing the droplets onto surfaces.
1.3 The method is specific to influenza viruses but could be adapted for work with other types of respiratory viruses or surrogates (Appendix X5).
1.4 This test method is suitable for working with a wide variety of environmental surfaces.
1.5 This test method does not address the performance of decontaminants against microbes expelled via blood splatter, vomit, or fecal contamination.
1.6 This test method should be performed only by those trained in bioaerosols, microbiology, or virology, or combinations thereof.
1.7 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.8 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
PDF Catalog
PDF Pages | PDF Title |
---|---|
1 | Scope Referenced Documents |
2 | Terminology Summary of Test Method Significance and Use Apparatus |
3 | Reagents and Materials Sampling, Test Specimens, and Test Units Experimental Design Test Procedure TABLE 1 |
4 | Calculation or Interpretation of Results |
5 | Report Precision and Bias Keywords X1. EXAMPLE DEVICE: OPERATION OF THE DROPLET CHAMBER TESTING SYSTEM X1.1 Diagram of the Droplet Loader X1.2 Parameters of the Droplet Loader |
6 | X1.3 Test Procedure X2. TCID50 ASSAY FOR INFLUENZA X2.1 Reagents FIG. X1.1 |
7 | X2.2 Method X3. EXAMPLE CALCULATION FOR TISSUE CULTURE INFECTIOUS DOSE (TCID50) ASSAY X3.1 24-Well Plate X3.2 96-Well Plate FIG. X3.1 FIG. X3.2 |
8 | X4. EXAMPLE CALCULATION FOR DATA QUALITY OBJECTIVES AND DECONTAMINATION EFFICIENCY X4.1 Example Data Set X4.2 Average log10TCID50/cm2 X4.3 Data Quality Objectives X4.4 Decontamination Efficiency X5. METHOD ADAPTATION FOR USING BACTERIOPHAGE MS2 X5.1 Scope X5.2 Referenced Documents X5.3 Terminology X5.4 Summary of Test Tethod X5.5 Significance and Use X5.6 Additional Equipment X5.7 Additional Reagents and Materials |
9 | X5.8 Sampling, Test Specimens, and Test Units X5.9 Experimental Design X5.10 Test Procedure X5.11 Calculation and Interpretation of Results X5.12 Additional Reporting X5.13 Precision and Bias X5.14 Additional Keywords X6. MS2 PLAQUE ASSAY X6.1 Preparation of E. coli (Day 1) X6.2 Inoculation of TSB With E. coli (Day 2) X6.3 Media Preparation and Plating (Day 3) X6.4 Prepare MS2 Soft-Agar Medium X6.5 Plating of Samples |